|
Market Closed -
OTC Markets
09:32:04 2026-05-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-80.00% | - |
| 24-08-20 | BIMI Holdings Inc.(OTCPK:BIMI) dropped from NASDAQ Composite Index | CI |
| 24-06-04 | Bimi Holdings Inc. Announces Directorate Changes | CI |
| Market Cap | 25.38M 22.13M 20.9M 18.98M 35.56M 2.44B 35.7M 250M 96.6M 1.24B 95.34M 93.23M 3.98B | P/E 2021 |
-0.39x | P/E 2022 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 33.1M 28.86M 27.25M 24.75M 46.37M 3.18B 46.56M 326M 126M 1.61B 124M 122M 5.2B | EV / Sales 2021 |
0.99x | EV / Sales 2022 | 1.05x |
| Free-Float |
100% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 week | -80.00% | ||
| 3 months | +9,900.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 4.13 |
| 5 years | 0 | | 133.5 |
| 10 years | 0 | | 1,250 |
| Manager | Title | Age | Since |
|---|---|---|---|
Baiqun Zhong
DFI | Director of Finance/CFO | 63 | 2021-05-20 |
Xiao Ping Wang
COO | Chief Operating Officer | 47 | 2020-02-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/12/24 | Free | Chairperson | 1,123,500 | 8.0229% | ||
| 2/28/24 | Sell | Chief Executive Officer | 4,000 | 0.0286% | ||
| 2/26/24 | Sell | Chief Executive Officer | 724 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -80.00% | -.--% | -99.99% | 6.98K | |
| -0.56% | -0.78% | +26.74% | +104.70% | 102B | |
| -0.42% | -3.92% | +50.21% | +155.62% | 52.42B | |
| +2.00% | -3.04% | -13.56% | +235.53% | 20.85B | |
| -1.61% | -2.39% | -12.78% | -10.97% | 7.88B | |
| -0.19% | -0.61% | -38.37% | -36.77% | 6.83B | |
| -0.19% | -4.19% | -4.96% | +15.34% | 6.41B | |
| -0.07% | -2.21% | -19.07% | -31.26% | 5.97B | |
| -1.57% | -1.63% | -3.72% | +17.24% | 4.94B | |
| -2.92% | +0.71% | +9.85% | +8.82% | 3.79B | |
| Average | -0.55% | -1.85% | -0.57% | +35.82% | 21.11B | |
| Weighted average by Cap. | -0.34% | -1.71% | +21.73% | +111.04% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 27.08M 23.61M 22.3M 20.25M 37.93M 2.6B 38.09M 267M 103M 1.32B 102M 99.47M 4.25B | 11.83M 10.32M 9.74M 8.85M 16.57M 1.14B 16.64M 117M 45.03M 577M 44.44M 43.45M 1.86B |
| Net income | -34.99M -30.51M -28.81M -26.16M -49.01M -3.36B -49.21M -345M -133M -1.71B -131M -129M -5.49B | -22.39M -19.53M -18.44M -16.74M -31.37M -2.15B -31.5M -221M -85.23M -1.09B -84.12M -82.25M -3.52B |
| Net Debt | 8.24M 7.18M 6.78M 6.16M 11.54M 790M 11.59M 81.23M 31.35M 402M 30.94M 30.25M 1.29B | 7.72M 6.73M 6.36M 5.77M 10.81M 741M 10.86M 76.13M 29.38M 377M 29M 28.35M 1.21B |
Employees
296
Sector
Pharmaceuticals
- Stock Market
- Stocks
- BIMI Stock
Select your edition
All financial news and data tailored to specific country editions
